• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App

    3/13/24 8:30:00 AM ET
    $GXAI
    Computer Software: Prepackaged Software
    Technology
    Get the next $GXAI alert in real time by email

    Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health.

    The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its position in the health and wellness industry.

    "By securing the rights to use this tech, we will be able to accelerate the development of our AI-enabled application for the Gaxos Health product offering," said Vadim Mats, CEO of Gaxos.AI. "This tech is intended to allow us to offer a more customized approach to delivering customers diet, nutrition, and tracking capabilities.

    The integration process will commence immediately, with both teams working closely to ensure a smooth transition. Gaxos is committed to leveraging this new technology to provide value to its customers and stakeholders.

    About Gaxos.ai Inc.

    Gaxos.AI isn't just developing applications; its aim is to redefine the human-AI relationship. Our offerings are being expanded to include health and wellness, as well as gaming. We're committed to addressing health, longevity, and entertainment through AI solutions.

    Forward-Looking Statements

    All statements other than statements of historical fact in this announcement are forward-looking statements that involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's filings with the SEC.

    Gaxos.ai Inc. Company Contact

    Investor Relations

    E:[email protected]

    T: 1-888-319-2499



    Get the next $GXAI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GXAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GXAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Gaxos.ai Inc.

      SC 13G - GAXOS.AI INC. (0001895618) (Subject)

      11/14/24 3:30:50 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    Leadership Updates

    Live Leadership Updates

    See more
    • Gaxos Health Expands Medical Advisory Board

      Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D.  is a Board-Ce

      4/25/24 8:45:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    Financials

    Live finance-specific insights

    See more
    • Gaxos Acquires Rights to AI-enabled Technology from Top Biohacking App

      Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio

      3/13/24 8:30:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $GXAI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SEC Form 4 filed by Director Holzer Adam

      4 - GAXOS.AI INC. (0001895618) (Issuer)

      4/15/25 7:03:36 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 4 filed by Director Grayson Scott

      4 - GAXOS.AI INC. (0001895618) (Issuer)

      4/15/25 7:02:46 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 4 filed by Director Feldman Roman

      4 - GAXOS.AI INC. (0001895618) (Issuer)

      4/15/25 7:01:32 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • Gaxos Labs Launches UnGPT.ai Setting a New Standard in Humanized AI

      Roseland, NJ, May 21, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of UnPGT.ai, a tool that makes text created by generative artificial intelligence sound natural and human. UnGPT introduces a real-time rewriting engine designed to convert machine-generated text into authentic, human-quality content without compromising meaning or context. UnGPT uses a proprietary multi-pass transformation model that outperforms leading AI detection tools and addresses one of the industry's fastest growing concerns: the need for undetectable, high-quality output in se

      5/21/25 8:00:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • Gaxos Labs Approved for Listing on Amazon Web Services (AWS) Marketplace

      Roseland, NJ , May 07, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that its product, Gaxos Labs for Game Developers and Publishers, has been officially approved for listing on Amazon Web Services (AWS) Marketplace, one of the cloud industry's largest software distribution platforms.  The approval marks a significant milestone in the Company's go-to-market strategy, enabling seamless deployment of Gaxos Labs by millions of AWS customers across 245 countries and territories. AWS Marketplace listing streamlines procurement for enterprise clients, simplifies software billi

      5/7/25 8:00:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • Gaxos Health Announces Launch of AI-Powered App

      Roseland, NJ, April 08, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced the official launch of the AI-enabled Gaxos Health mobile application for iOS and Android for its customers.  The new AI-driven app is designed to personalize and optimize individual health outcomes through smart technology and science-backed routines. The Gaxos Health app leverages proprietary algorithms to deliver goal-based wellness protocols including nutrition, fitness, supplementation, and behavioral coaching. "We are thrilled to announce the launch of the Gaxos Health app," said Vadim Mats, CEO

      4/8/25 7:30:00 AM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology

    $GXAI
    SEC Filings

    See more
    • SEC Form 10-Q filed by Gaxos.ai Inc.

      10-Q - GAXOS.AI INC. (0001895618) (Filer)

      5/15/25 4:30:53 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-K filed by Gaxos.ai Inc.

      10-K - GAXOS.AI INC. (0001895618) (Filer)

      3/28/25 5:27:35 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 8-K12B filed by Gaxos.ai Inc.

      8-K12B - GAXOS.AI INC. (0001895618) (Filer)

      3/4/25 4:15:18 PM ET
      $GXAI
      Computer Software: Prepackaged Software
      Technology